Everpine Capital

Everpine sources through international technology and brand acquisition, targeting companies with IP that Chinese domestic industries already require. Rather than competing in broad auctions, the firm leans on operational partners to identify carve-outs and IP transfers where the acquired technology can be embedded into a Chinese subsidiary or distribution channel. The pipeline includes medtech devices, aviation manufacturing protocols, and educational brands.

Everpine’s strategy centers on direct control positions and co-investments. The firm’s website does not describe a fund-of-funds program, but it does form joint-venture vehicles — such as the logistics-industrial park fund with 坤鼎集团 — that sit alongside its direct equity positions. The model is closer to a direct principal investing platform than a multi-manager allocator.

The firm does not publish an exclusion list, but its investment pattern reveals a preference for physical technology and branded services: industrial chemistry, aviation manufacturing, robotics hardware, medtech devices, and operational education. Pure software, consumable internet, and financial services are absent from the known portfolio.